随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨

路透中文

Jul 07

BUZZ-随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨

7月7日 - ** 基因治疗公司MeiraGTx MGTX.O 股价在盘前交易中上涨7.3%，至14.90美元

** 该公司表示已从奥伯兰资本（Oberland Capital）获得最高4亿美元融资，用于推进三项处于后期阶段的实验性基因疗法

** 此次融资包括最高3.75亿美元与未来销售特许权使用费挂钩的非稀释性融资，以及最高2,500万美元的股权投资

** 公司表示已收到1.35亿美元，其中包括1.25亿美元的未来特许权使用费及1,000万美元的股权投资

** 预计在2027-2028年获得积极的临床试验数据并取得监管批准后，还将获得额外的1.5亿美元

** MeiraGTx表示，奥伯兰资本可能为新产品或业务发展再提供1亿美元，并可额外购入价值1,500万美元的MeiraGTx股票

** 截至上一交易日收盘，该股年内累计涨幅约为75%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2649982340"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2649982340\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2649982340?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-07-07 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649982340","market":"hk","top_or_hot":-1,"title":"随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨</title></head><body><p><span>7月7日</span><span> - </span>** 基因治疗公司MeiraGTx <span>MGTX.O</span> 股价在盘前交易中上涨7.3%，至14.90美元</p><p>** 该公司表示已从奥伯兰资本（Oberland Capital）获得最高4亿美元融资，用于推进三项处于后期阶段的实验性基因疗法</p><p>** 此次融资包括最高3.75亿美元与未来销售特许权使用费挂钩的非稀释性融资，以及最高2,500万美元的股权投资</p><p>** 公司表示已收到1.35亿美元，其中包括1.25亿美元的未来特许权使用费及1,000万美元的股权投资</p><p>** 预计在2027-2028年获得积极的临床试验数据并取得监管批准后，还将获得额外的1.5亿美元</p><p>** MeiraGTx表示，奥伯兰资本可能为新产品或业务发展再提供1亿美元，并可额外购入价值1,500万美元的MeiraGTx股票 </p><p>** 截至上一交易日收盘，该股年内累计涨幅约为75%</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-07-07 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨</title></head><body><p><span>7月7日</span><span> - </span>** 基因治疗公司MeiraGTx <span>MGTX.O</span> 股价在盘前交易中上涨7.3%，至14.90美元</p><p>** 该公司表示已从奥伯兰资本（Oberland Capital）获得最高4亿美元融资，用于推进三项处于后期阶段的实验性基因疗法</p><p>** 此次融资包括最高3.75亿美元与未来销售特许权使用费挂钩的非稀释性融资，以及最高2,500万美元的股权投资</p><p>** 公司表示已收到1.35亿美元，其中包括1.25亿美元的未来特许权使用费及1,000万美元的股权投资</p><p>** 预计在2027-2028年获得积极的临床试验数据并取得监管批准后，还将获得额外的1.5亿美元</p><p>** MeiraGTx表示，奥伯兰资本可能为新产品或业务发展再提供1亿美元，并可额外购入价值1,500万美元的MeiraGTx股票 </p><p>** 截至上一交易日收盘，该股年内累计涨幅约为75%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4S4390Z7:1","article_id":"2649982340","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2649982340","pubTimestamp":1783424469,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨7月7日-** 基因治疗公司MeiraGTxMGTX.O股价在盘前交易中上涨7.3%，至14.90美元** 该公司表示已从奥伯兰资本（Oberland Capital）获得最高4亿美元融资，用于推进三项处于后期阶段的实验性基因疗法** 此次融资包括最高3.75亿美元与未来销售","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","MGTX":"Meiragtx Holdings Plc"},"translate_title":"MeiraGTx shares rise as Oberland Capital pledges up to $400 million for late-stage gene therapy projects","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MGTX":0.9},"content_text":"BUZZ-随着奥伯兰资本（Oberland Capital）承诺为后期基因疗法项目投入高达4亿美元，MeiraGTx股价上涨7月7日 - ** 基因治疗公司MeiraGTx MGTX.O 股价在盘前交易中上涨7.3%，至14.90美元** 该公司表示已从奥伯兰资本（Oberland Capital）获得最高4亿美元融资，用于推进三项处于后期阶段的实验性基因疗法** 此次融资包括最高3.75亿美元与未来销售特许权使用费挂钩的非稀释性融资，以及最高2,500万美元的股权投资** 公司表示已收到1.35亿美元，其中包括1.25亿美元的未来特许权使用费及1,000万美元的股权投资** 预计在2027-2028年获得积极的临床试验数据并取得监管批准后，还将获得额外的1.5亿美元** MeiraGTx表示，奥伯兰资本可能为新产品或业务发展再提供1亿美元，并可额外购入价值1,500万美元的MeiraGTx股票 ** 截至上一交易日收盘，该股年内累计涨幅约为75%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}